A detailed history of Barrow Hanley Mewhinney & Strauss LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Barrow Hanley Mewhinney & Strauss LLC holds 14,976 shares of JNJ stock, worth $2.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,976
Previous 152,029 90.15%
Holding current value
$2.33 Million
Previous $24 Million 90.9%
% of portfolio
0.01%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $19.8 Million - $21.6 Million
-137,053 Reduced 90.15%
14,976 $2.19 Million
Q1 2024

May 13, 2024

SELL
$155.22 - $162.74 $17.5 Million - $18.3 Million
-112,529 Reduced 42.53%
152,029 $24 Million
Q4 2023

Feb 12, 2024

BUY
$145.6 - $158.88 $2.94 Million - $3.21 Million
20,226 Added 8.28%
264,558 $41.5 Million
Q3 2023

Nov 13, 2023

SELL
$155.75 - $174.48 $72,112 - $80,784
-463 Reduced 0.19%
244,332 $38.1 Million
Q2 2023

Aug 10, 2023

BUY
$154.35 - $166.11 $15.8 Million - $17 Million
102,607 Added 72.16%
244,795 $40.5 Million
Q1 2023

May 11, 2023

SELL
$151.05 - $180.26 $8.99 Million - $10.7 Million
-59,538 Reduced 29.51%
142,188 $22 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $184,870 - $207,477
-1,154 Reduced 0.57%
201,726 $35.6 Million
Q3 2022

Nov 10, 2022

BUY
$161.33 - $179.52 $4.9 Million - $5.45 Million
30,358 Added 17.6%
202,880 $33.1 Million
Q2 2022

Aug 11, 2022

SELL
$168.19 - $186.01 $616,248 - $681,540
-3,664 Reduced 2.08%
172,522 $30.6 Million
Q1 2022

May 13, 2022

SELL
$158.14 - $179.59 $10.4 Million - $11.8 Million
-65,803 Reduced 27.19%
176,186 $31.2 Million
Q4 2021

Feb 10, 2022

SELL
$155.93 - $173.01 $18.7 Million - $20.7 Million
-119,658 Reduced 33.09%
241,989 $41.4 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $15.4 Million - $17.1 Million
-95,111 Reduced 20.82%
361,647 $58.4 Million
Q2 2021

Aug 12, 2021

SELL
$159.48 - $171.07 $96.9 Million - $104 Million
-607,647 Reduced 57.09%
456,758 $75.2 Million
Q1 2021

May 13, 2021

SELL
$153.07 - $170.48 $7.86 Million - $8.76 Million
-51,379 Reduced 4.6%
1,064,405 $175 Million
Q4 2020

Feb 11, 2021

SELL
$137.11 - $157.38 $31.9 Million - $36.6 Million
-232,797 Reduced 17.26%
1,115,784 $176 Million
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $23.5 Million - $25.8 Million
-167,690 Reduced 11.06%
1,348,581 $201 Million
Q2 2020

Aug 12, 2020

SELL
$128.81 - $155.51 $4.41 Million - $5.32 Million
-34,200 Reduced 2.21%
1,516,271 $213 Million
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $39.5 Million - $54.7 Million
355,140 Added 29.71%
1,550,471 $203 Million
Q4 2019

Feb 12, 2020

BUY
$127.5 - $146.44 $55.7 Million - $64 Million
436,843 Added 57.59%
1,195,331 $174 Million
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $46.5 Million - $52.1 Million
-366,414 Reduced 32.57%
758,488 $98.1 Million
Q2 2019

Aug 13, 2019

SELL
$131.15 - $144.24 $681 Million - $749 Million
-5,195,744 Reduced 82.2%
1,124,902 $157 Million
Q1 2019

May 14, 2019

SELL
$125.72 - $139.79 $38.4 Million - $42.7 Million
-305,285 Reduced 4.61%
6,320,646 $884 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $81.7 Million - $98.3 Million
-664,993 Reduced 9.12%
6,625,931 $855 Million
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $203 Million - $238 Million
-1,666,669 Reduced 18.61%
7,290,924 $1.01 Billion
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $57.1 Million - $63 Million
-478,174 Reduced 5.07%
8,957,593 $1.09 Billion
Q1 2018

May 14, 2018

SELL
$125.1 - $148.14 $74.2 Million - $87.8 Million
-592,727 Reduced 5.91%
9,435,767 $1.21 Billion
Q4 2017

Feb 09, 2018

SELL
$131.22 - $143.62 $75.9 Million - $83.1 Million
-578,595 Reduced 5.45%
10,028,494 $1.4 Billion
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $1.37 Billion - $1.44 Billion
10,607,089
10,607,089 $1.38 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Barrow Hanley Mewhinney & Strauss LLC Portfolio

Follow Barrow Hanley Mewhinney & Strauss LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barrow Hanley Mewhinney & Strauss LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barrow Hanley Mewhinney & Strauss LLC with notifications on news.